Nucala 100 MG/ML syringeml

Ended Awarded Last action

Contract number
SPE2DR26FHLF6
Awardee
Awarding agency
Obligated
$11,591

Award facts

Contract value 100% obligated
$11,591.04 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The Defense Logistics Agency issued a $11,591.04 delivery order to DMS Pharmaceutical Group Inc. on May 6, 2026, for NUCALA 100 mg/ml syringes under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).

DMS Pharmaceutical is a woman-owned small business holding the single-award indefinite delivery contract SPE2DX under PPV-G GEN V, which runs through December 31, 2036, with a $499.999 billion ceiling. Place of performance is Park Ridge, Illinois. The order has a firm fixed price and an ultimate completion date of May 7, 2026.

Quick answers

Who was awarded contract SPE2DR26FHLF6?

SPE2DR26FHLF6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on May 6, 2026.

How much is contract SPE2DR26FHLF6 worth?

The government has obligated $11,591 on SPE2DR26FHLF6.

Is contract SPE2DR26FHLF6 an order under another contract?

Yes. SPE2DR26FHLF6 is a delivery order under SPE2DR25D9222, an indefinite delivery contract.

Was contract SPE2DR26FHLF6 competed?

The extent of competition for SPE2DR26FHLF6 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login